VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression. Clin Cancer Res. 2018 07 15; 24(14):3366-3376.
View in:
PubMed
subject areas
3' Untranslated Regions
Antineoplastic Agents, Immunological
Biomarkers, Tumor
Cell Line, Tumor
Cytotoxicity, Immunologic
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Genes, Reporter
HLA-A Antigens
Humans
Interferon-gamma
Lymphocytes, Tumor-Infiltrating
Melanoma
Neoplasms
Programmed Cell Death 1 Receptor
Protein Binding
RNA-Binding Proteins
authors with profiles
MICHAEL A DAVIES
AMJAD HOSSAIN TALUKDER
PATRICK HWU
CHANTALE BERNATCHEZ
SCOTT ERIC WOODMAN
WEIYI PENG
RODABE N AMARIA
JENNIFER WARGO
CARA L HAYMAKER
ANIL KORKUT